About this trial
The effects of single dose injection of platelet rich plasma or conditioned serum in the knee joint in patients with knee osteoarthritis will be compared
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of knee osteoarthritis according to ACR criteria at least 6 months ago.
Being between grade 1-2 according to the Kellgren-Lawrence radiological classification.
Not having had PRP injection in the last year.
Knee pain ≥ 5 according to the visual pain scale.
Disqualifiers
Those with significant neurological or cardiovascular disorders.
Those with active thrombovascular disease.
Those with joint or skin infections.
Those who have recently had an infectious disease.
Trial design
Parallel
Treatments tested in this trial
Autologous Platelet-Rich Plasma (PRP)
DrugAutologous Platelet-Rich Plasma (PRP) will be injected intra-articularly in patients with knee osteoarthritis
Conditioned serum (CS)
DrugAutologous conditionedserum (CS) will be injected intra-articularly in patients with knee osteoarthritis
Treatment groups
Trial outcomes
Primary outcomes
Visual pain scale score
Visual pain scale score (min 0-max 10), higher scores indicate better results
Sponsors and contacts
Click on the lead sponsor to view all of their trials.